Reduction of Nasopharyngeal Carriage of Streptococcus pneumoniae after Administration of a 9-Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care Centers

A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up p...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 185; no. 7; pp. 927 - 936
Main Authors Dagan, Ron, Givon-Lavi, Noga, Zamir, Orly, Sikuler-Cohen, Merav, Guy, Lior, Janco, Jacob, Yagupsky, Pablo, Fraser, Drora
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.04.2002
University of Chicago Press
Subjects
Online AccessGet full text
ISSN0022-1899
1573-6613
1537-6613
DOI10.1086/339525

Cover

Abstract A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged ⩽36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.
AbstractList A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged < or =36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.
A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged ⩽36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.
A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged less than or equal to 36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.
A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged < or =36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate vaccine on the carriage rate of pneumococci. Of 3750 cultures done on nasopharyngeal samples obtained from subjects during a 2-year follow-up period after vaccination, 65% were positive for Streptococcus pneumoniae. In all age windows, the rate of carriage of vaccine-type pneumococci was lower among subjects who received the pneumococcal vaccine than among control subjects, because the acquisition rate was lower in the former group. The effect was most pronounced among subjects aged < or =36 months. The sample size enabled us to study protection against carriage of S. pneumoniae serotypes 6B, 9V, 14, 19F, and 23F; significant protection against all serotypes except 19F was seen in the pneumococcal-vaccine group. The rate of carriage of serotype 6A (not included in the vaccine) was also reduced significantly, but the rate of carriage of serotype 19A (not included in the vaccine) was not. The rate of carriage of non-vaccine-type pneumococci (excluding serotype 6A) was higher in the pneumococcal-vaccine group than in the control group.
Author Dagan, Ron
Givon-Lavi, Noga
Yagupsky, Pablo
Fraser, Drora
Guy, Lior
Zamir, Orly
Sikuler-Cohen, Merav
Janco, Jacob
Author_xml – sequence: 1
  givenname: Ron
  surname: Dagan
  fullname: Dagan, Ron
  email: rdagan@bgumail.bgu.ac.il
  organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 2
  givenname: Noga
  surname: Givon-Lavi
  fullname: Givon-Lavi, Noga
  organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 3
  givenname: Orly
  surname: Zamir
  fullname: Zamir, Orly
  organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 4
  givenname: Merav
  surname: Sikuler-Cohen
  fullname: Sikuler-Cohen, Merav
  organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 5
  givenname: Lior
  surname: Guy
  fullname: Guy, Lior
  organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 6
  givenname: Jacob
  surname: Janco
  fullname: Janco, Jacob
  organization: Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 7
  givenname: Pablo
  surname: Yagupsky
  fullname: Yagupsky, Pablo
  organization: Clinical Microbiology Laboratories, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
– sequence: 8
  givenname: Drora
  surname: Fraser
  fullname: Fraser, Drora
  organization: Epidemiology Department, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13596877$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11920317$$D View this record in MEDLINE/PubMed
BookMark eNqF0suO0zAUBuAIDWI6A7wByCxgRcAnTuJkWZVLQeUiGCo0G8t1Too7qR1sR2IeibfEbTodCQmx8uL_8ss-OWfJibEGk-Qh0BdAq_IlY3WRFXeSCRScpWUJ7CSZUJplKVR1fZqceb-hlOas5PeSU4A6owz4JPn9BZtBBW0NsS35KL3tf0h3bdYoOzKTzmm5xl30NTjsg1VWqcGT3uCwtUZLJLIN6Mi02WqjfXDypkuSOl3KDk0gn_d69-mu1JrNsJYByVIqpQ2SYMmFbZoOnSfTENA02qzJK3m9uwCSWayI0f3kbis7jw8O53ny7c3ri9k8XXx6-242XaQqz7KQcqghh4rzVYucVVxisypKULJZlfkqw7qmWYPQ1i0FVXDYi6yCrGJc1k3LzpNnY2_v7M8BfRBb7RV2nTRoBy84FDkvM_5fCFUOAAwifHyAw2qLjeid3sYZi5u_EMHTA5A-jqh10ijtbx0r6jK-KLrno1POeu-wFUqH_cDj3HUngIrdMohxGW4veOTHxr_hkxHaof-3eTSajQ_WHRWjwDjjVczTMY9LgL-OuXRXooygEPPvl-Ly_Xw5KxYL8YH9Adjk1v0
CODEN JIDIAQ
CitedBy_id crossref_primary_10_1056_NEJMe068038
crossref_primary_10_1038_s41598_023_31820_4
crossref_primary_10_1097_01_inf_0000143645_58215_f0
crossref_primary_10_1097_INF_0000000000001341
crossref_primary_10_1371_journal_pone_0030548
crossref_primary_10_1056_NEJMoa022823
crossref_primary_10_1128_CVI_00117_10
crossref_primary_10_1016_j_vaccine_2014_12_023
crossref_primary_10_1016_j_ijid_2019_02_003
crossref_primary_10_1586_14760584_7_9_1367
crossref_primary_10_1128_JCM_43_6_2656_2661_2005
crossref_primary_10_1016_S0264_410X_03_00361_X
crossref_primary_10_1086_593339
crossref_primary_10_1136_ebn_6_1_e1
crossref_primary_10_1111_j_1541_0420_2012_01826_x
crossref_primary_10_4161_hv_26109
crossref_primary_10_1016_j_vaccine_2005_08_029
crossref_primary_10_1097_01_inf_0000435805_25366_64
crossref_primary_10_1016_j_vaccine_2015_02_012
crossref_primary_10_1016_j_vaccine_2006_11_032
crossref_primary_10_1016_j_vaccine_2009_04_009
crossref_primary_10_1086_422651
crossref_primary_10_1128_IAI_00601_10
crossref_primary_10_1038_s41598_017_08717_0
crossref_primary_10_1093_cid_cis371
crossref_primary_10_1097_01_inf_0000154326_77617_3e
crossref_primary_10_1007_s00520_009_0804_2
crossref_primary_10_1097_INF_0b013e31824de9f6
crossref_primary_10_1128_IAI_71_11_6199_6204_2003
crossref_primary_10_1128_IAI_72_9_5031_5040_2004
crossref_primary_10_1080_21645515_2017_1287640
crossref_primary_10_1186_s12879_019_4254_2
crossref_primary_10_1186_1471_2334_9_102
crossref_primary_10_1080_21645515_2016_1261772
crossref_primary_10_1592_phco_2005_25_9_1193
crossref_primary_10_1016_j_vaccine_2005_10_053
crossref_primary_10_1016_j_vaccine_2014_06_091
crossref_primary_10_1016_S1473_3099_08_70281_0
crossref_primary_10_1086_596064
crossref_primary_10_1371_journal_pone_0068940
crossref_primary_10_1002_14651858_CD004977_pub2
crossref_primary_10_1128_CMR_00018_12
crossref_primary_10_1053_j_spid_2004_01_011
crossref_primary_10_1097_INF_0b013e318168d28a
crossref_primary_10_2165_00003495_200565020_00005
crossref_primary_10_1016_j_micpath_2010_02_009
crossref_primary_10_1586_14760584_5_4_553
crossref_primary_10_1016_j_medmal_2011_02_001
crossref_primary_10_1016_S0031_3939_11_70577_7
crossref_primary_10_1016_j_anl_2021_07_003
crossref_primary_10_1016_j_jim_2004_11_006
crossref_primary_10_1186_1471_2334_13_357
crossref_primary_10_1016_S0140_6736_10_62225_8
crossref_primary_10_1016_j_mimet_2008_08_010
crossref_primary_10_1111_j_1469_0691_2009_02775_x
crossref_primary_10_1371_journal_pone_0072198
crossref_primary_10_1016_j_coi_2012_05_005
crossref_primary_10_1111_j_1442_200X_2010_03212_x
crossref_primary_10_1371_journal_pone_0027102
crossref_primary_10_1097_00006454_200210000_00016
crossref_primary_10_3109_00365548_2011_601754
crossref_primary_10_1172_JCI33947
crossref_primary_10_1080_14760584_2019_1627207
crossref_primary_10_1093_aje_kwm076
crossref_primary_10_1089_mdr_2009_0056
crossref_primary_10_1586_erv_09_78
crossref_primary_10_1111_j_1469_0691_2006_01502_x
crossref_primary_10_1080_00365540500321512
crossref_primary_10_1016_j_ijmm_2004_04_004
crossref_primary_10_1086_423379
crossref_primary_10_1016_j_vaccine_2008_07_016
crossref_primary_10_1097_01_inf_0000069760_65826_f2
crossref_primary_10_1016_j_vaccine_2014_03_017
crossref_primary_10_1186_s12879_020_05674_4
crossref_primary_10_1111_biom_12473
crossref_primary_10_1128_JCM_41_1_386_392_2003
crossref_primary_10_1016_j_cpem_2013_04_005
crossref_primary_10_1016_j_vaccine_2015_11_012
crossref_primary_10_1097_INF_0b013e3181a78185
crossref_primary_10_1093_cid_ciz1164
crossref_primary_10_1097_01_inf_0000069761_11093_c3
crossref_primary_10_1016_S1473_3099_10_70318_2
crossref_primary_10_1097_01_inf_0000109221_50972_53
crossref_primary_10_1586_eri_09_112
crossref_primary_10_1016_S1473_3099_15_70007_1
crossref_primary_10_1097_INF_0b013e31814da70c
crossref_primary_10_1086_382696
crossref_primary_10_1016_S0140_6736_03_13772_5
crossref_primary_10_1016_j_vaccine_2010_02_065
crossref_primary_10_1016_j_vaccine_2017_07_019
crossref_primary_10_1098_rspb_2013_1939
crossref_primary_10_1007_s00467_008_0989_5
crossref_primary_10_1097_01_inf_0000195784_27503_f0
crossref_primary_10_1007_s11908_008_0031_x
crossref_primary_10_1586_14760584_5_4_517
crossref_primary_10_1016_S0882_4010_03_00048_2
crossref_primary_10_1542_peds_112_4_862
crossref_primary_10_1099_mic_0_28394_0
crossref_primary_10_1097_INF_0b013e3181658c5c
crossref_primary_10_1016_j_annemergmed_2006_10_026
crossref_primary_10_1128_JCM_40_11_3903_3908_2002
crossref_primary_10_1086_522984
crossref_primary_10_1007_s12275_014_3583_5
crossref_primary_10_1517_14712598_2012_636348
crossref_primary_10_1016_j_vaccine_2009_05_062
crossref_primary_10_1016_S1696_2818_03_71587_X
crossref_primary_10_1016_S1473_3099_06_70520_5
crossref_primary_10_1186_1471_2334_6_14
crossref_primary_10_1586_14760584_5_5_651
crossref_primary_10_1016_j_femsim_2004_03_013
crossref_primary_10_1128_CVI_00248_12
crossref_primary_10_1016_j_vaccine_2013_06_040
crossref_primary_10_1136_bmjopen_2018_027233
crossref_primary_10_1016_j_vaccine_2005_08_092
crossref_primary_10_1586_eri_09_132
crossref_primary_10_1128_IAI_73_10_7043_7046_2005
crossref_primary_10_1371_journal_ppat_1000159
crossref_primary_10_1016_j_vaccine_2012_08_012
crossref_primary_10_1016_S0140_6736_06_69614_1
crossref_primary_10_1128_IAI_72_10_5807_5813_2004
crossref_primary_10_1016_j_vaccine_2020_04_050
crossref_primary_10_1186_1471_2334_5_41
crossref_primary_10_1016_j_vaccine_2007_04_088
crossref_primary_10_1016_j_femsre_2004_05_002
crossref_primary_10_1016_j_idc_2005_05_008
crossref_primary_10_1016_j_vaccine_2003_11_038
crossref_primary_10_1128_spectrum_00591_24
crossref_primary_10_1086_428585
crossref_primary_10_1016_j_epidem_2008_07_001
crossref_primary_10_1016_j_vaccine_2012_03_058
crossref_primary_10_1097_01_inf_0000243163_85163_a8
crossref_primary_10_3201_eid1007_030612
crossref_primary_10_1016_j_anpedi_2012_05_026
crossref_primary_10_1016_S0011_393X_02_80074_1
crossref_primary_10_1093_infdis_jis447
crossref_primary_10_1080_14760584_2020_1750377
crossref_primary_10_1371_journal_pmed_1001107
crossref_primary_10_1086_432721
crossref_primary_10_1016_j_arcped_2004_11_013
crossref_primary_10_1016_j_meegid_2007_07_011
crossref_primary_10_1586_14760584_7_1_83
crossref_primary_10_1111_j_1365_2249_2004_02628_x
crossref_primary_10_1016_j_vaccine_2009_09_113
crossref_primary_10_1128_JCM_44_3_999_1017_2006
crossref_primary_10_1016_j_vaccine_2004_12_014
crossref_primary_10_1111_j_1469_0691_2004_00869_x
crossref_primary_10_1038_nbt728
crossref_primary_10_1097_INF_0b013e3181a06303
crossref_primary_10_1128_CVI_00344_08
crossref_primary_10_1086_527401
crossref_primary_10_1586_erv_12_53
crossref_primary_10_1128_JCM_00265_07
crossref_primary_10_1016_S0031_3955_03_00025_7
crossref_primary_10_1016_S1473_3099_18_30660_1
crossref_primary_10_1097_INF_0000000000003223
crossref_primary_10_1007_s40121_021_00406_w
crossref_primary_10_1016_j_diagmicrobio_2012_11_021
crossref_primary_10_1128_JCM_42_10_4449_4452_2004
crossref_primary_10_1097_MRM_0b013e32833a345f
crossref_primary_10_1177_2333794X221078698
crossref_primary_10_1016_S0095_4543_03_00004_6
crossref_primary_10_1093_cid_cis554
crossref_primary_10_1016_j_clim_2024_110295
crossref_primary_10_3389_fimmu_2022_1078904
crossref_primary_10_1016_j_vaccine_2011_09_074
crossref_primary_10_1542_peds_113_3_443
crossref_primary_10_3947_ic_2016_48_4_257
crossref_primary_10_1097_MCC_0000000000000338
crossref_primary_10_1002_eji_200839091
crossref_primary_10_1586_14760584_4_2_207
crossref_primary_10_1111_j_1469_0691_2006_01544_x
crossref_primary_10_1128_IAI_73_11_7718_7726_2005
crossref_primary_10_1097_01_inf_0000145478_36236_1e
crossref_primary_10_1371_journal_pcbi_1006333
crossref_primary_10_1371_journal_pmed_1001017
crossref_primary_10_1080_21645515_2015_1095414
crossref_primary_10_4236_wjv_2013_32007
crossref_primary_10_1016_j_yapd_2006_04_015
crossref_primary_10_1186_1471_2334_10_90
crossref_primary_10_1097_00001432_200406000_00002
crossref_primary_10_1016_j_vaccine_2004_05_003
crossref_primary_10_1097_INF_0b013e31825cb9f9
crossref_primary_10_1128_IAI_72_5_2659_2670_2004
crossref_primary_10_1177_00034894051140S110
crossref_primary_10_1089_mdr_2008_0782
crossref_primary_10_1097_01_inf_0000257425_24492_11
crossref_primary_10_1371_journal_pone_0085459
crossref_primary_10_1371_journal_pmed_0020015
crossref_primary_10_1016_S1473_3099_04_00938_7
crossref_primary_10_1111_j_1469_0691_2006_1502_1_x
crossref_primary_10_1016_j_vaccine_2004_02_038
crossref_primary_10_1128_CVI_05369_11
crossref_primary_10_1016_j_bbmt_2019_10_006
crossref_primary_10_1016_j_vaccine_2006_09_011
crossref_primary_10_1093_cid_cit428
crossref_primary_10_1097_INF_0b013e3181b78e6e
crossref_primary_10_1046_j_1365_3083_2003_01292_x
crossref_primary_10_2165_00148581_200810020_00002
crossref_primary_10_1016_j_vaccine_2015_01_003
crossref_primary_10_1016_j_vaccine_2008_05_073
crossref_primary_10_1016_j_mimet_2007_04_008
crossref_primary_10_1371_journal_pone_0195799
crossref_primary_10_1016_j_vaccine_2003_09_036
crossref_primary_10_1097_00006454_200308001_00003
crossref_primary_10_1038_mi_2015_5
crossref_primary_10_1080_17513758_2011_592548
crossref_primary_10_1097_00020840_200312000_00002
crossref_primary_10_1016_j_ijporl_2005_06_022
crossref_primary_10_1016_j_jmii_2017_08_022
crossref_primary_10_1186_s13104_019_4330_0
crossref_primary_10_1371_journal_pone_0049143
crossref_primary_10_1542_peds_2007_2017
crossref_primary_10_1097_INF_0000000000002452
crossref_primary_10_1371_journal_pone_0114286
crossref_primary_10_1016_j_vaccine_2010_03_030
crossref_primary_10_1097_01_idc_0000230541_02089_8c
crossref_primary_10_1016_j_jiac_2019_12_009
crossref_primary_10_1128_JCM_00665_09
crossref_primary_10_1086_504802
crossref_primary_10_1371_journal_pone_0082047
crossref_primary_10_1016_j_ijporl_2004_04_008
crossref_primary_10_1007_s10096_005_1313_y
crossref_primary_10_1016_j_vaccine_2021_04_068
crossref_primary_10_1086_587941
crossref_primary_10_1097_INF_0000000000001800
crossref_primary_10_1097_INF_0000000000000717
crossref_primary_10_1128_JCM_43_1_74_83_2005
crossref_primary_10_1097_00020840_200210000_00001
crossref_primary_10_1073_pnas_0600636103
crossref_primary_10_1128_AAC_48_6_2206_2213_2004
crossref_primary_10_1016_j_idc_2015_07_009
crossref_primary_10_1542_peds_2007_2703
crossref_primary_10_4236_wjv_2015_52011
crossref_primary_10_1186_1471_2431_10_4
crossref_primary_10_2165_00019053_200624020_00004
crossref_primary_10_1542_pir_30_5_155
crossref_primary_10_1038_srep14952
crossref_primary_10_1016_j_diagmicrobio_2013_03_028
crossref_primary_10_1016_S0399_077X_03_00002_7
crossref_primary_10_1016_j_vaccine_2004_06_009
ContentType Journal Article
Copyright Copyright 2002 Infectious Diseases Society of America
2002 by the Infectious Diseases Society of America 2002
2002 INIST-CNRS
Copyright_xml – notice: Copyright 2002 Infectious Diseases Society of America
– notice: 2002 by the Infectious Diseases Society of America 2002
– notice: 2002 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
7X8
DOI 10.1086/339525
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE



Bacteriology Abstracts (Microbiology B)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1573-6613
1537-6613
EndPage 936
ExternalDocumentID 11920317
13596877
10_1086_339525
10.1086/339525
30137378
ark_67375_HXZ_ZJHVC5LL_M
Genre Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1TH
29K
2AX
2WC
36B
3O-
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACHIC
ACPRK
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFHKK
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BSCLL
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
VH1
W2D
W8F
WH7
X7H
X7M
Y6R
YAYTL
YKOAZ
YXANX
ZGI
ZXP
~91
AASNB
ADACV
ADJQC
ADRIX
AFXEN
DOOOF
ESX
JSODD
M49
1KJ
41~
AAFWJ
AAJQQ
AAPGJ
AAWDT
AAYOK
AAYXX
ABDPE
ABSMQ
ACFRR
ACPQN
ACUTJ
ACVCV
ACZBC
ADMTO
AEKPW
AFFQV
AFQQW
AFSHK
AGKRT
AGMDO
AHGBF
AJDVS
APJGH
AQDSO
AQKUS
AVNTJ
BZKNY
CITATION
EIHJH
H13
MBLQV
OBFPC
O~Y
P0-
TMA
ZE2
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
YIF
7QL
C1K
7X8
ID FETCH-LOGICAL-c422t-719141877bfe7387aedb561cadb64b2e9902de1f9f01c57187aed2812837a9df3
ISSN 0022-1899
IngestDate Sun Sep 28 07:29:53 EDT 2025
Sun Sep 28 11:38:24 EDT 2025
Wed Feb 19 01:30:20 EST 2025
Mon Jul 21 09:11:53 EDT 2025
Thu Apr 24 23:09:47 EDT 2025
Tue Jul 01 03:23:27 EDT 2025
Wed Sep 11 04:50:58 EDT 2024
Fri Jun 20 02:31:44 EDT 2025
Sat Sep 20 11:01:51 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Human
Preschool age
Immunoprotection
Vaccination
Infant
Asymptomatic
Nasopharynx
Polyvalent vaccine
Streptococcus pneumoniae
Infection
Streptococcaceae
Streptococcal infection
Bacteriosis
Bacteria
Micrococcales
Carrier
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c422t-719141877bfe7387aedb561cadb64b2e9902de1f9f01c57187aed2812837a9df3
Notes istex:8A56C0FA2AE68916B453BD91FB668B1A1228859A
ark:/67375/HXZ-ZJHVC5LL-M
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 11920317
PQID 18411131
PQPubID 23462
PageCount 10
ParticipantIDs proquest_miscellaneous_71547627
proquest_miscellaneous_18411131
pubmed_primary_11920317
pascalfrancis_primary_13596877
crossref_citationtrail_10_1086_339525
crossref_primary_10_1086_339525
oup_primary_10_1086_339525
jstor_primary_30137378
istex_primary_ark_67375_HXZ_ZJHVC5LL_M
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2002-04-01
PublicationDateYYYYMMDD 2002-04-01
PublicationDate_xml – month: 04
  year: 2002
  text: 2002-04-01
  day: 01
PublicationDecade 2000
PublicationPlace Chicago, IL
PublicationPlace_xml – name: Chicago, IL
– name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAbbrev The Journal of Infectious Diseases
PublicationTitleAlternate The Journal of Infectious Diseases
PublicationYear 2002
Publisher The University of Chicago Press
University of Chicago Press
Publisher_xml – name: The University of Chicago Press
– name: University of Chicago Press
SSID ssj0004367
Score 2.2397327
Snippet A double-blind, randomized study involving 264 toddlers attending day care centers was conducted to document the effect of a 9-valent pneumococcal conjugate...
SourceID proquest
pubmed
pascalfrancis
crossref
oup
jstor
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 927
SubjectTerms Bacteriology
Biological and medical sciences
Carrier State - microbiology
Carrier State - prevention & control
Child care
Child Day Care Centers
Child, Preschool
Children
Conjugate vaccines
Control groups
Day care centers
Double-Blind Method
Female
Fundamental and applied biological sciences. Psychology
Humans
Infant
Major Articles
Male
Microbiology
Nasopharynx - microbiology
Otitis media
Permeability, membrane transport, intracellular transport
Pneumococcal Infections - microbiology
Pneumococcal Infections - prevention & control
Pneumococcal vaccine
Pneumococcal Vaccines - administration & dosage
Pneumococcal Vaccines - immunology
Serotyping
Streptococcus pneumoniae
Streptococcus pneumoniae - classification
Streptococcus pneumoniae - immunology
Streptococcus pneumoniae - isolation & purification
Toddlers
Vaccination
Vaccines, Conjugate - administration & dosage
Vaccines, Conjugate - immunology
Title Reduction of Nasopharyngeal Carriage of Streptococcus pneumoniae after Administration of a 9-Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care Centers
URI https://api.istex.fr/ark:/67375/HXZ-ZJHVC5LL-M/fulltext.pdf
https://www.jstor.org/stable/30137378
https://www.ncbi.nlm.nih.gov/pubmed/11920317
https://www.proquest.com/docview/18411131
https://www.proquest.com/docview/71547627
Volume 185
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1573-6613
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 0022-1899
  databaseCode: KQ8
  dateStart: 19970401
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1573-6613
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 0022-1899
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1573-6613
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 0022-1899
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKJhASQjAYdMDwA_BSZWrjJE4epwKrpnYg6KqqL5GTOFUZpFWbVpRvxAfhe3Fn5y-jCHiJqsSxTr2f4_Pd7-4IeWEK04xiJIVZcNKxpLQMtFoN6dgBCyLHk0KxfC-c3qV1PrbHjcaPCmtpnQYn4bff5pX8j1bhHugVs2T_QbPFpHADfoN-4Qoahutf6fgD1l3NTb4LgR0JxHKbTLFYcFcsQQLtEsDQ8yKdw7cvXK9ai0SuQcSZkFmH8HoBXZ0x6RkjgRtS670aja8qN0PyaY2Ot9ZIhBiSR9N1OEcfx3LVOk3RoY6-h9diqzKblPM449jnJnCZjJbVq9BsMBAsCxZVWt1PsyhVyRU4m23midEXm5mOOk2LbWUivswU_N5VKKofZ1drkM0oslAGcik2NVeHWWHIlGVz_0RVydMTOq7uulR-4u0Klnnlg-3pygTZ3u_pYizXtpW2inIx5tk6S_uXEt0M6zYy7t4g-yZ3HGykcTYumUYWc3hetB4lq7S40lPWbKJ9XN5fc3psnnd5ZyFWoOdYd1vZfRxSZtHwHrmbKZKeanDeJw2ZHJCbusPp9oDcGmTcjQfke4FWOo9pHa00Rys-qqGVlmilCq20jlZ8QdAcrbSKVlqglWZopemc5milBVopoBUFkDRD60Ny-fbNsNszskYhRghfmNTgWKSw43IexJIzlwsZBXAuCEUUOFZgSrC4zEh2Yi9ud0IbrDEcYYJp6zIuvChmh2QvmSfyMaHCtbkVSodhJcTI5iJ27ZhJGfLACZ121CQvc1X5YVZFH5u5fPYVm8N1fK3SJnlejFvoujHXRrxSmi4ei-UVsiy57ffGE39y3ht17X7fHzTJoYJCMTCHW5McATZ2Tn9cg0w5jNmeA_8VSJhjyIctBeOEIpGw2v2Oa4EFxDq7R3A4eIEVBXM80uArZ4cTI9gJ_GiX0E_I7XJpPyV76XItn4FdnwbHatX8BETN_z0
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduction+of+Nasopharyngeal+Carriage+of+Streptococcus+pneumoniae+after+Administration+of+a+9-Valent+Pneumococcal+Conjugate+Vaccine+to+Toddlers+Attending+Day+Care+Centers&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Dagan%2C+Ron&rft.au=Givon-Lavi%2C+Noga&rft.au=Zamir%2C+Orly&rft.au=Sikuler-Cohen%2C+Merav&rft.date=2002-04-01&rft.pub=University+of+Chicago+Press&rft.issn=0022-1899&rft.volume=185&rft.issue=7&rft.spage=927&rft.epage=936&rft_id=info:doi/10.1086%2F339525&rft.externalDocID=30137378
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon